This year’s top papers deepen our understanding of autism’s genetics and reveal mixed results from trials of autism therapies.

No diet is likely to treat autistic people on a large scale, but diets based on a genetic profile may bring big benefits to a few.

The American Academy of Pediatrics has, for the first time in 12 years, overhauled its recommendations for identifying and supporting autistic children.

Two agency letters put California-based Liveyon on warning and alert the public to the risks associated with stem-cell based therapies for autism.

Understanding how gaze differs in autistic people may help improve their lives.

Studies of the brain’s sensory system may provide unique insight into the brain mechanisms that underlie autism and could point to possible treatments.

Autistic people have long maintained that repetitive behaviors are beneficial. Emerging evidence in support of this idea is shaping new therapies.

A mix of two drugs eases hypersensitivity to noise in mice missing an autism gene — offering the promise of a similar treatment for autistic people.

Special diets that eliminate certain foods or contain added supplements have minimal impact on autism traits, according to a review of 27 clinical trials.

Thousands of research presentations, five days: Spectrum looks back at the 2019 Society for Neuroscience annual meeting in Chicago.